Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms
- PMID:9737724
- DOI: 10.1096/fasebj.12.12.1211
Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms
Abstract
This study demonstrates the involvement of the MT2 (Mel1b) melatonin receptor in mediating phase advances of circadian activity rhythms by melatonin. In situ hybridization histochemistry with digoxigenin-labeled oligonucleotide probes revealed for the first time the expression of mt1 and MT2 melatonin receptor mRNA within the suprachiasmatic nucleus of the C3H/HeN mouse. Melatonin (0.9 to 30 microg/mouse, s.c.) administration during 3 days at the end of the subjective day (CT 10) to C3H/HeN mice kept in constant dark phase advanced circadian rhythms of wheel running activity in a dose-dependent manner [EC50=0.72 microg/mouse; 0.98+/-0.08 h (n=15) maximal advance at 9 microg/mouse]. Neither the selective MT2 melatonin receptor antagonists 4P-ADOT and 4P-PDOT (90 microg/mouse, s.c.) nor luzindole (300 microg/mouse, s.c.), which shows 25-fold higher affinity for the MT2 than the mt1 subtype, affected the phase of circadian activity rhythms when given alone at CT 10. All three antagonists, however, shifted to the right the dose-response curve to melatonin, as they significantly reduced the phase shifting effects of 0.9 and 3 microg melatonin. This is the first study to demonstrate that melatonin phase advances circadian rhythms by activation of a membrane-bound melatonin receptor and strongly suggests that this effect is mediated through the MT2 melatonin receptor subtype within the circadian timing system. We conclude that the MT2 melatonin receptor subtype is a novel therapeutic target for the development of subtype-selective analogs for the treatment of circadian sleep and mood-related disorders.
Similar articles
- Activation of MT(2) melatonin receptors in rat suprachiasmatic nucleus phase advances the circadian clock.Hunt AE, Al-Ghoul WM, Gillette MU, Dubocovich ML.Hunt AE, et al.Am J Physiol Cell Physiol. 2001 Jan;280(1):C110-8. doi: 10.1152/ajpcell.2001.280.1.C110.Am J Physiol Cell Physiol. 2001.PMID:11121382
- Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.Rawashdeh O, Hudson RL, Stepien I, Dubocovich ML.Rawashdeh O, et al.Chronobiol Int. 2011 Feb;28(1):31-8. doi: 10.3109/07420528.2010.532894.Chronobiol Int. 2011.PMID:21182402Free PMC article.
- Circadian rhythm of mt1 melatonin receptor expression in the suprachiasmatic nucleus of the C3H/HeN mouse.Masana MI, Benloucif S, Dubocovich ML.Masana MI, et al.J Pineal Res. 2000 Apr;28(3):185-92. doi: 10.1034/j.1600-079x.2001.280309.x.J Pineal Res. 2000.PMID:10739306
- Mammalian melatonin receptors: molecular biology and signal transduction.von Gall C, Stehle JH, Weaver DR.von Gall C, et al.Cell Tissue Res. 2002 Jul;309(1):151-62. doi: 10.1007/s00441-002-0581-4. Epub 2002 May 18.Cell Tissue Res. 2002.PMID:12111545Review.
- Molecular pharmacology, regulation and function of mammalian melatonin receptors.Dubocovich ML, Rivera-Bermudez MA, Gerdin MJ, Masana MI.Dubocovich ML, et al.Front Biosci. 2003 Sep 1;8:d1093-108. doi: 10.2741/1089.Front Biosci. 2003.PMID:12957828Review.
Cited by
- Functional MT1 and MT2 melatonin receptors in mammals.Dubocovich ML, Markowska M.Dubocovich ML, et al.Endocrine. 2005 Jul;27(2):101-10. doi: 10.1385/ENDO:27:2:101.Endocrine. 2005.PMID:16217123Review.
- The Role of the Melatoninergic System in Circadian and Seasonal Rhythms-Insights From Different Mouse Strains.Pfeffer M, von Gall C, Wicht H, Korf HW.Pfeffer M, et al.Front Physiol. 2022 Apr 12;13:883637. doi: 10.3389/fphys.2022.883637. eCollection 2022.Front Physiol. 2022.PMID:35492605Free PMC article.Review.
- Melatonin receptor genes in vertebrates.Li DY, Smith DG, Hardeland R, Yang MY, Xu HL, Zhang L, Yin HD, Zhu Q.Li DY, et al.Int J Mol Sci. 2013 May 27;14(6):11208-23. doi: 10.3390/ijms140611208.Int J Mol Sci. 2013.PMID:23712359Free PMC article.Review.
- Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.Zisapel N.Zisapel N.CNS Drugs. 2001;15(4):311-28. doi: 10.2165/00023210-200115040-00005.CNS Drugs. 2001.PMID:11463135Review.
- Association of Dietary Behaviors and Sleep Quality: Results from the Adults Chronic Diseases and Risk Factors Survey of 2015 in Ningbo, China.Kong F, Li H, Xu G, Ying Y, Gong Q, Zhao J, Zhang X, Zhang L, Liu S, Han L.Kong F, et al.Int J Environ Res Public Health. 2018 Aug 23;15(9):1823. doi: 10.3390/ijerph15091823.Int J Environ Res Public Health. 2018.PMID:30142936Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases